Kessler, L. J., Łabuz, G., Auffarth, G. U., & Khoramnia, R. (2022). Biomarkers to predict the success of treatment with the intravitreal 0.19 mg fluocinolone acetonide implant in uveitic macular edema. Pharmaceutics, 14(4), . https://doi.org/10.3390/pharmaceutics14040688
Chicago Style (17th ed.) CitationKessler, Lucy Joanne, Grzegorz Łabuz, Gerd U. Auffarth, and Ramin Khoramnia. "Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 Mg Fluocinolone Acetonide Implant in Uveitic Macular Edema." Pharmaceutics 14, no. 4 (2022). https://doi.org/10.3390/pharmaceutics14040688.
MLA (9th ed.) CitationKessler, Lucy Joanne, et al. "Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 Mg Fluocinolone Acetonide Implant in Uveitic Macular Edema." Pharmaceutics, vol. 14, no. 4, 2022, https://doi.org/10.3390/pharmaceutics14040688.